17
Jun

The U.K.’s GW Pharmaceuticals saw its shares hit an all-time high after disclosing promising efficacy data for Epidiolex, a cannabinoid treatment for a rare form of epilepsy.

…read more

Source: GW spikes on positive results for cannabis-based epilepsy drug

    

0 No comments